EDGAR Filing Documents for 0001193125-22-090029

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001193125-22-090029

Filing Date

2022-03-30

Accepted

2022-03-30 17:14:46

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	d341935ds3.htm	S-3	476217
2	EX-1.2	d341935dex12.htm	EX-1.2	161342
3	EX-4.4	d341935dex44.htm	EX-4.4	289306
4	EX-4.6	d341935dex46.htm	EX-4.6	91961
5	EX-4.7	d341935dex47.htm	EX-4.7	93256
6	EX-4.8	d341935dex48.htm	EX-4.8	83214
7	EX-5.1	d341935dex51.htm	EX-5.1	28275
8	EX-23.1	d341935dex231.htm	EX-23.1	1443
9	EX-FILING FEES	d341935dexfilingfees.htm	EX-FILING FEES	65499
10	GRAPHIC	g341935g00a04.jpg	GRAPHIC	70647
11	GRAPHIC	g341935g00a35.jpg	GRAPHIC	68024
12	GRAPHIC	g341935g00a57.jpg	GRAPHIC	67064
13	GRAPHIC	g341935g0325085555173.jpg	GRAPHIC	2406
	Complete submission text file	0001193125-22-090029.txt		1578899

Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063

Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295

Bolt Biotherapeutics, Inc. (Filer) CIK: 0001641281 (see all company filings)